Traffic at the intersection of neurotrophic factor signaling and neurodegeneration (Q78819278)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Traffic at the intersection of neurotrophic factor signaling and neurodegeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Jean-Dominique Delcroix

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

William C Mobley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

published in

Trends in Neurosciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

73-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

Genetically engineered mouse models of neurodegenerative diseases

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Nerve growth factor signaling, neuroprotection, and neural repair

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Alzheimer's disease in Down's syndrome: clinicopathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

A mouse model for Down syndrome exhibits learning and behaviour deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

The cholinergic system in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Neurotrophic factors in Alzheimer's and Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Nerve growth factor in Alzheimerʼs disease: defective retrograde transport to nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

NGF Amplifies Expression of NGF Receptor Messenger RNA in Forebrain Cholinergic Neurons of Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

New frontiers in Alzheimer's disease genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Cytokines and Neurotrophins Interact in Normal and Diseased States

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Interleukin-1, neuroinflammation, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

The role of complement in Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Neurodegenerative tauopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Tau in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Cdk5 behind the wheel: a role in trafficking and transport?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Neurotoxicity induces cleavage of p35 to p25 by calpain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Impaired proteasome function in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Aggresomes: a cellular response to misfolded proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Aggresomes, inclusion bodies and protein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Alpha-synuclein and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

1 reference

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Complex relationship between Parkin mutations and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Parkinson's disease: one biochemical pathway to fit all genes?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Chaperoning brain degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Beyond the Qs in the polyglutamine diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2802%2900038-3

7 January 2021

10.1016/S0166-2236(02)00038-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12536130%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference